Intel is partnering with an Oregon-based university to develop computing technologies for managing volumes of biomedical data that scientists use to detect complex diseases and discover new treatments.
Oregon Health & Science University and Intel aim to create information tools and workflow offerings to help the scientific community understand genetics behind diseases like cancer at a patient level, the university said Monday.
Stephen Pawlowski, senior fellow and chief technology officer at Intel’s data center and connected systems group, said the collaboration aims to leverage Intel’s experience in developing computing technology with OHSU’s background in visualizing and understanding biological information.
A team comprising of OHSU biomedical experts and Intel engineers is building a research data facility equipped with an Intel supercomputing system for the project.
The multiyear project will have researchers initially focus on molecular profiling patients’ tumors to study how a disease progresses and use this information to monitor tumor response to treatment, OHSU says.
Computer scientists, biophysicists, genomicists, bio-informaticists, biologists and others will work with researchers at the OHSU Knight Cancer Institute for the project.